Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Sitala seals $670M deal for Fosun immune disease drug
Right on the heels of a similar deal, Fosun Pharma has outlicensed a second inflammatory disease candidate to a Western biotech startup.
Angus Liu
Aug 26, 2025 2:44pm
Sponsored
How Bottom-Up QC Improvements Fix Product Problems Before They Start
Aug 25, 2025 8:00am
Sanofi snags BioMarin leader to serve as CMO
Aug 26, 2025 11:06am
Lilly's oral GLP-1 charts 10.5% weight loss in diabetic patients
Aug 26, 2025 6:45am
Regeneron posts phase 3 win, advancing push to muscle in on gMG
Aug 26, 2025 9:41am
Fierce Pharma
Akeso, Summit's PD-1xVEGF drug meets OS goal for the first time
Aug 26, 2025 11:36am
More News
ProVerum raises $80M for stent treatment for BPH
Aug 26, 2025 2:12pm
Abbott absorbable stent for peripheral arteries heads to Europe
Aug 26, 2025 12:35pm
Lineage tunes up hearing loss transplant with $12M research pact
Aug 26, 2025 11:00am
Novartis pens BioArctic neuro pact worth $30M upfront
Aug 26, 2025 8:30am